Stockscreener 앱 받기
6.49
4.70%
-0.32
시장 영업 전:
6.29
-0.20
-3.08%
Fulcrum Therapeutics Inc 주식(FULC)의 최신 뉴스
How high can Fulcrum Therapeutics Inc. stock goShort Term Profit Strategy with Entry Cues - Newser
Why Fulcrum Therapeutics Inc. stock attracts strong analyst attentionWeekly Market Direction and Sector Summary - Newser
Is Fulcrum Therapeutics Inc. meeting your algorithmic filter criteriaFree Consistent Profit Pattern Recognition Tools - Newser
What recovery options are there for Fulcrum Therapeutics Inc.Retirement Investment Outlook and Return Summary - Newser
When is the best time to exit Fulcrum Therapeutics Inc.Real Time Stock Movement and Alerts - Newser
Does Fulcrum Therapeutics Inc. qualify in momentum factor screeningSwing Candidate List with Trade Cues - Newser
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - The Globe and Mail
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Comparing Fulcrum Therapeutics Inc. in custom built stock radarsFree Capital Efficiency Optimized Stock Alerts - Newser
Is Fulcrum Therapeutics Inc. stock ready for a breakoutLow Volatility Stock Analysis With Confidence - Newser
Fulcrum Therapeutics (NASDAQ:FULC) Stock Rating Lowered by Wall Street Zen - Defense World
Published on: 2025-08-09 00:54:39 - Newser
Forecasting Fulcrum Therapeutics Inc. price range with options dataFree Stock Portfolio Allocation Guidance - Newser
Is Fulcrum Therapeutics Inc. a Top Dividend Stock to Watch in 2025Short-Term Market Movement Forecast Report - Newser
Fulcrum Therapeutics Awards $6.96 Stock Options Package: 4-Year Vesting Terms Revealed - Stock Titan
Real time pattern detection on Fulcrum Therapeutics Inc. stockPredicted Market Direction Based on Momentum - Newser
Quant Models Detect Momentum Reversal in Fulcrum Therapeutics Inc.Low Volatility Stable Growth Picks Rank High - beatles.ru
Fulcrum defended at H.C. Wainwright after data for sickle cell disease drug - MSN
Chart overlay techniques for tracking Fulcrum Therapeutics Inc.Free Long Hold Safe Return Strategy - Newser
Fulcrum Therapeutics Reports Q2 2025 Financial Results - TipRanks
Technical Bounce Expected in Fulcrum Therapeutics Inc. Next WeekAI Based High Gain Watchlist Scanner Shared - beatles.ru
Strategy Insiders Buy In While Analysts Predict Big Upside - The Globe and Mail
Applying big data sentiment scoring on Fulcrum Therapeutics Inc.Buy Alert Based on RSI and Volume - Newser
Technical signs of recovery in Fulcrum Therapeutics Inc.AI Entry Timing Prediction for Swing Traders - Newser
Fulcrum Therapeutics Inc. Stock Analysis and ForecastAchieve breakthrough gains with smart trades - Jammu Links News
What catalysts could drive Fulcrum Therapeutics Inc. stock higher in 2025Build wealth with long-term growth strategies - Jammu Links News
What are analysts’ price targets for Fulcrum Therapeutics Inc. in the next 12 monthsBuild a portfolio that stands the test of time - Jammu Links News
Why is Fulcrum Therapeutics Inc. stock attracting strong analyst attentionMassive stock growth - Jammu Links News
Is Fulcrum Therapeutics Inc. a good long term investmentUnlock powerful trading strategies for gains - Jammu Links News
What is the risk reward ratio of investing in Fulcrum Therapeutics Inc. stockBuild a winning investment strategy today - Jammu Links News
What analysts say about Fulcrum Therapeutics Inc. stockAchieve impressive returns with smart timing - Jammu Links News
What is Fulcrum Therapeutics Inc. company’s growth strategyUnlock powerful market insights for success - Jammu Links News
Fulcrum Therapeutics shares slide 17% after sickle cell trial results - MSN
When is Fulcrum Therapeutics Inc. stock expected to show significant growthFree Market Dynamics Reports - jammulinksnews.com
How strong is Fulcrum Therapeutics Inc. company’s balance sheetMaximize returns with timely market signals - Jammu Links News
How does Fulcrum Therapeutics Inc. generate profit in a changing economyHigh-profit capital plays - Jammu Links News
What institutional investors are buying Fulcrum Therapeutics Inc. stockInvest smarter with cutting-edge analytics - jammulinksnews.com
Is Fulcrum Therapeutics Inc. stock overvalued or undervaluedAccess exclusive market insights for free - Jammu Links News
FY2025 EPS Estimates for FULC Raised by Cantor Fitzgerald - Defense World
Will Fulcrum Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsOversold Opportunity Scanner with RSI Data - Newser
Q3 Earnings Forecast for FULC Issued By Leerink Partnrs - Defense World
Are Bears Losing Grip on Fulcrum Therapeutics Inc.Reliable Investment Entry Signals Confirmed by Charts - metal.it
How to interpret RSI for Fulcrum Therapeutics Inc. stockTen-Year Sector Performance and Summary Analysis - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):